Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Drostanolone propionate
evidence profile

Injectable anabolic-androgenic steroid with historical oncology use. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Drostanolone propionate: conceptual scientific illustration for Clinical / Endocrine Pharmacology
VISUAL GUIDE · Drostanolone propionate

Clinical / Endocrine Pharmacology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

Drostanolone propionate is classified here as Injectable anabolic-androgenic steroid with historical oncology use. Historical breast-cancer use does not establish modern performance benefit or product safety. No current FDA-approved product was identified; prohibited by WADA at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.

01

ENTITY FACTS

What should readers identify first?

MOLECULEDrostanolone propionate
PHARMACOLOGYInjectable anabolic-androgenic steroid with historical oncology use
PRIMECORE CLASSB
EVIDENCE GRADED
RESEARCH TOPICClinical / Endocrine Pharmacology
LAST REVIEWED2026-09-01

What remains unknown?

Insufficient data in the current dataset

What limits these conclusions?

  • Drostanolone propionate molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. DEA · Steroids Drug Fact Sheet
  2. NIDA · Steroids and other APEDs
  3. WADA · 2026 Prohibited List
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Drostanolone propionate?

Drostanolone propionate is described pharmacologically as Injectable anabolic-androgenic steroid with historical oncology use. Drostanolone propionate is classified here as Injectable anabolic-androgenic steroid with historical oncology use. Historical breast-cancer use does not establish modern performance benefit or product safety. No current FDA-approved product was identified; prohibited by WADA at all times. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.

Does Drostanolone propionate have strong evidence?

PrimeCoreBio records Evidence Grade D. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Drostanolone propionate approved everywhere?

No global conclusion should be inferred. PrimeCore Class B must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice